Article
Sponsored Content
Catalent Pharma Solutions
Catalent Biologics’ Bloomington, Indiana facility provides sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across a number of biological drug product formats.
Catalent Biologics’ Bloomington, Indiana facility provides sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across a number of biological drug product formats.
The site recently achieved regulatory approval for a 20th commercial product and investment of over $100 million has been announced to expand manufacturing and packaging capabilities, increasing flexibility and capacity.
Catalent
CPhI North America Booth #1206
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
